返回
COMA: efficient structure-constrained molecular generation using contractive and margin losses
DOI:10.1186/s13321-023-00679-y.png)
摘要
En 中文
BackgroundStructure-constrained molecular generation is a promising approach to drug discovery. The goal of structure-constrained molecular generation is to produce a novel molecule that is similar to a given source molecule (e.g. hit molecules) but has enhanced chemical properties (for lead optimization). Many structure-constrained molecular generation models with superior performance in improving chemical properties have been proposed; however, they still have difficulty producing many novel molecules that satisfy both the high structural similarities to each source molecule and improved molecular properties.MethodsWe propose a structure-constrained molecular generation model that utilizes contractive and margin loss terms to simultaneously achieve property improvement and high structural similarity. The proposed model has two training phases; a generator first learns molecular representation vectors using metric learning with contractive and margin losses and then explores optimized molecular structure for target property improvement via reinforcement learning.ResultsWe demonstrate the superiority of our proposed method by comparing it with various state-of-the-art baselines and through ablation studies. Furthermore, we demonstrate the use of our method in drug discovery using an example of sorafenib-like molecular generation in patients with drug resistance.
Keyword:
Drug design
Molecular optimization
Goal-directed molecular generation
Structure-constrained molecular generation
Deep generative model
Metric learning
Contrastive learning
Reinforcement learning
AI总结
对已上传原文的论文进行重点信息的提取,主要内容包括:简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。
期刊
IF:
5.7
论文数:
1.5K
被引数:
1.1W
机构
引用论文
AutoDock Vina 1.2.0: New Docking Methods, Expanded Force Field, and Python BindingsAutoDock Vina 1.2.0: 新的对接方法,扩展的力场和Python绑定
Plasma Hsp90 levels in patients with systemic sclerosis and relation to lung and skin involvement: a cross-sectional and longitudinal study系统性硬化症患者的血浆Hsp90水平及其与肺和皮肤受累的关系: 一项横断面和纵向研究
SCIENTIFIC REPORTS
IF3.9
SOX9 enhances sorafenib resistance through upregulating ABCG2 expression in hepatocellular carcinoma
Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5
CANCER RESEARCH
IF16.6

